PO-1011 Efficacy of PD-1 inhibition in recurrent Head and Neck cancer. A national prospective cohort study. (August 2021) - Søby, S.; Gothelf, A.; Gyldenkerne, N.; Bentzen, J.; Nowicka-Matus, K.; Tramm, T.; Eriksen, J.G.